Insight into contact force local impedance technology for predicting effective pulmonary vein isolation.
atrial fibrillation
catheter ablation
contact force
lesion formation
local impedance
pulmonary vein isolation
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
02
2023
accepted:
19
06
2023
medline:
21
7
2023
pubmed:
21
7
2023
entrez:
21
7
2023
Statut:
epublish
Résumé
Highly localized impedance (LI) measurements during atrial fibrillation (AF) ablation have the potential to act as a reliable predictor of the durability of the lesions created. We aimed to collect data on the procedural parameters affecting LI-guided ablation in a large multicenter registry. A total of 212 consecutive patients enrolled in the CHARISMA registry and undergoing their first pulmonary vein (PV) isolation for paroxysmal and persistent AF were included. In all, 13,891 radiofrequency (RF) applications of ≥3 s duration were assessed. The first-pass PV isolation rate was 93.3%. A total of 80 PV gaps were detected. At successful ablation spots, baseline LI and absolute LI drop were larger than at PV gap spots (161.4 ± 19 Ω vs. 153.0 ± 13 Ω, An LI drop >21 Ω at anterior sites and >18 Ω at posterior sites predicts successful ablation. A higher CF was associated with an increased likelihood of ideal LI drop. The combination of good CF and adequate LI drop allows a significant reduction in RF DT. http://clinicaltrials.gov/, identifier: NCT03793998.
Sections du résumé
Background
UNASSIGNED
Highly localized impedance (LI) measurements during atrial fibrillation (AF) ablation have the potential to act as a reliable predictor of the durability of the lesions created.
Objective
UNASSIGNED
We aimed to collect data on the procedural parameters affecting LI-guided ablation in a large multicenter registry.
Methods
UNASSIGNED
A total of 212 consecutive patients enrolled in the CHARISMA registry and undergoing their first pulmonary vein (PV) isolation for paroxysmal and persistent AF were included.
Results
UNASSIGNED
In all, 13,891 radiofrequency (RF) applications of ≥3 s duration were assessed. The first-pass PV isolation rate was 93.3%. A total of 80 PV gaps were detected. At successful ablation spots, baseline LI and absolute LI drop were larger than at PV gap spots (161.4 ± 19 Ω vs. 153.0 ± 13 Ω,
Conclusion
UNASSIGNED
An LI drop >21 Ω at anterior sites and >18 Ω at posterior sites predicts successful ablation. A higher CF was associated with an increased likelihood of ideal LI drop. The combination of good CF and adequate LI drop allows a significant reduction in RF DT.
Clinical trial registration
UNASSIGNED
http://clinicaltrials.gov/, identifier: NCT03793998.
Identifiants
pubmed: 37476572
doi: 10.3389/fcvm.2023.1169037
pmc: PMC10354239
doi:
Banques de données
ClinicalTrials.gov
['NCT03793998']
Types de publication
Journal Article
Langues
eng
Pagination
1169037Informations de copyright
© 2023 Lepillier, Maggio, De Sanctis, Malacrida, Stabile, Zakine, Champ-Rigot, Anselmino, Segreti, Dell'Era, Garnier, Mascia, Pandozi, Dello Russo, Scaglione, Cosaro, Ferraro, Paziaud, Maglia and Solimene.
Déclaration de conflit d'intérêts
MM and GC are employees of Boston Scientific. MA is a consultant for Boston Scientific and Biosense Webster and a clinical proctor for Medtronic, and has received educational fees from Abbott. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor TS declared a past co-authorship with the author FS.
Références
Pacing Clin Electrophysiol. 1992 Jan;15(1):22-7
pubmed: 1370996
Pacing Clin Electrophysiol. 2021 Oct;44(10):1717-1723
pubmed: 34498748
PLoS One. 2021 Sep 16;16(9):e0257050
pubmed: 34529678
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005831
pubmed: 29618475
Heart Rhythm. 2020 Aug;17(8):1371-1380
pubmed: 32240822
J Cardiovasc Electrophysiol. 2013 Nov;24(11):1210-5
pubmed: 23865557
Europace. 2022 Mar 2;24(3):390-399
pubmed: 34480548
Europace. 2021 Jul 18;23(7):1042-1051
pubmed: 33550380
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1540-1548
pubmed: 33851484
J Cardiovasc Electrophysiol. 2023 Jan;34(1):71-81
pubmed: 36378816
J Cardiovasc Electrophysiol. 2020 Sep;31(9):2319-2327
pubmed: 32613661
Europace. 2020 Nov 1;22(11):1645-1652
pubmed: 32879974
J Interv Card Electrophysiol. 2022 Apr;63(3):749-758
pubmed: 35322330
JACC Clin Electrophysiol. 2018 Jan;4(1):99-108
pubmed: 29600792
Heart Rhythm. 2017 Oct;14(10):e275-e444
pubmed: 28506916
Pacing Clin Electrophysiol. 1997 Dec;20(12 Pt 1):2899-910
pubmed: 9455749
Europace. 2019 Jan 1;21(Supplement_1):i34-i42
pubmed: 30801126
J Interv Card Electrophysiol. 2022 Aug;64(2):333-339
pubmed: 33891228
Heart Rhythm. 2012 Nov;9(11):1789-95
pubmed: 22820056